Skip to content

New Daily Persistent Headache Survey

New Daily Persistent Headache Patient Experience Survey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05984719
Acronym
NDPH
Enrollment
803
Registered
2023-08-09
Start date
2023-06-19
Completion date
2024-01-31
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

New Daily Persistent Headache, New Daily Persistent Headache (NDPH)

Keywords

Constant headache, Refractory headache disorder

Brief summary

Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey. Research design: Online survey of patients with new daily persistent headache. Risks: Risks include a breach of confidentiality as well as fatigue from taking the survey online. Importance of knowledge that may recently be expected to result: The study aims to discover new information in a very understudied disease. This information could, in future studies, help change the diagnostic criteria or lead to new treatment options.

Interventions

None listed

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with NDPH that have been diagnosed by a health care professional (no documentation is needed, participant must simply state that he or she has been diagnosed)

Exclusion criteria

* Unable to speak English (the survey is only in English) * Unable to use a computer to take the online survey

Design outcomes

Primary

MeasureTime frame
Survey dataAt study completion, expected to be in 6-12 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026